We have investigated the eects of the truncated trkB receptor isoform T1 (trkB.T1) by transient transfection into mouse N2a neuroblastoma cells. We observed that expression of trkB.T1 leads to a striking change in cell morphology characterized by outgrowth of ®lopodia and processes. A similar morphological response was also observed in SH-SY5Y human neuroblastoma cells and NIH3T3 ®broblasts transfected with trkB.T1. N2a cells lack endogenous expression of trkB isoforms, but express barely detectable amounts of its ligands, brainderived neurotrophic factor (BDNF) and neurotrophin-4 (NT-4). The morphological change was ligand-independent, since addition of exogenous BDNF or NT-4 or blockade of endogenous trkB ligands did not in¯uence this response. Filopodia and process outgrowth was signi®cantly suppressed when full-length trkB.TK+ was cotransfected together with trkB.T1 and this inhibitory eect was blocked by tyrosine kinase inhibitor K252a. Transfection of trkB.T1 deletion mutants showed that the morphological response is dependent on the extracellular, but not the intracellular domain of the receptor. Our results suggest a novel ligand-independent role for truncated trkB in the regulation of cellular morphology.
Introduction
Neuroblastomas, which are derived from the embryonal neural crest cells, are among the most common tumors in children. These tumors harbor various stages of dierentiation, and in some children, spontaneous or therapy-induced tumor maturation to benign ganglioneuromas can occur. Unfortunately, tumors in the majority of children over one year of age often lead to death (Vaughan III et al., 1979) .
Neurotrophins function through trk family of receptor tyrosine kinases (Barbacid, 1994; Lewin and Barde, 1996) . Endogenous trk receptors are expressed in many human neuroblastoma cells and their expression appears to correlate with the differentiation stage. In particular, expression of trkA (Martin-Zanca et al., 1989) , the signal transducing receptor for nerve growth factor (NGF) (Kaplan et al., 1991a,b; Klein et al., 1991a; Barbacid, 1994) or trkC, the receptor for neurotrophin-3 (NT-3) (Lamballe et al., 1991) is associated with a higher dierentiation stage and more favorable outcome (Nakagawara et al., 1993; Yamashiro et al., 1996) . In contrast, expression of trkB (Klein et al., 1989; Middlemas et al., 1991) , the receptor for brain-derived neurotrophic factor (BDNF) (Klein et al., 1991b; Soppet et al., 1991; Squinto et al., 1991) and neurotrophin 4/5 (NT-4) (Berkemeier et al., 1991; HallboÈ oÈ k et al., 1991; Ip et al., 1992; Klein et al., 1992) is correlated with N-myc expression and malignant phenotype (Nakagawara et al., 1994) . Dierentiation of several human neuroblastoma cells with retinoic acid induces trkB expression Lucarelli et al., 1994 Lucarelli et al., , 1995 . Retinoic acid dierentiated SH-SY5Y human neuroblastoma cells, which express trkB display characteristics of metastatic cells, such as increased survival, disaggregation, and invasiveness in response to BDNF treatment (Matsumoto et al., 1995) .
TrkB is alternatively spliced into several dierent isoforms (Klein et al., 1990; Middlemas et al., 1991) . Most notably, alternative splicing produces, in addition to the full-length, tyrosine kinase-containing isoform (trkB.TK+) also truncated tyrosine kinase-lacking isoforms. The truncated trkB.TK7 isoforms share with the trkB.TK+ form identical extracellular and transmembrane domains and a 12-amino acid intracellular juxta-membrane region, but diverge thereafter and contain only a short intracellular tail region (Klein et al., 1990; Middlemas et al., 1991) . Rodents have two dierent trkB.TK7 isoforms: trkB.T1, with an 11 amino acid tail; and trkB.T2, with a unique 9 amino acid tail . Only one trkB.TK7 isoform corresponding to the T1 form has been reported in humans, and this isoform is highly conserved in evolution with humans, rats and chick, sharing an identical intracellular region (Bio et al., 1995; Shelton et al., 1995) .
The physiological functions of trkB.TK7 isoforms are unclear. TrkB.TK7 isoforms, in particular T1, are expressed in glial cells and in the ependymal lining of brain ventricles, whereas trkB.TK+ forms are restricted to neurons. It has therefore been proposed that trkB.TK7 forms act as`sponges' to restrict BDNF diusion within brain parenchyma (Klein et al., 1990; Beck et al., 1993; FriseÂ n et al., 1993; Bio et al., 1995) . Indeed, trkB.T1 is internalized into leptomeningeal cells and its expression pattern in developing chick nervous system is consistent with a compartmentalization function (Bio et al., 1995) . TrkB.T1-mediated internalization may clear extracellular BDNF and shorten the time that it is available to trkB.TK+ receptors. Rubio (1997) has shown that astrocytes use truncated trkB to take up, store and deliver BDNF in intact, biologically active form. Recently, Baxter et al. (1997) have provided evidence that trkB.TK7 receptors may induce signal transduction on their own by causing ligand-dependent acidi®cation determined by a cytosensor device. These observations raise the possibility that trkB.TK7 isoforms may have an active role in shaping the response to neurotrophins.
TrkB.TK7 isoform is also expressed in neurons and at least within hippocampus, a subset of neurons appear to express both trkB.TK+ and trkB.TK7 isoforms . As dimerization of tyrosine kinase domains is necessary for the initiation of signal transduction, the trkB.TK7 isoforms are expected to function as dominant negative receptors when expressed together with trkB.TK+ in the same cell (Jing et al., 1992) . Indeed, when both isoforms are coexpressed in Xenopus oocytes, trkB.TK7 form inhibits BDNF-induced calcium eux in a dosedependent manner (Eide et al., 1993) . Further, coinjection of trkB.T1 isoform inhibits BDNF-induced survival in trkB.TK+ microinjected mouse sympathetic neurons also dose-dependently (Ninkina et al., 1996) . Taken together, these data suggest that expression of trkB.TK7 isoforms may modulate the neurotrophin-induced signal transduction in neurons.
Neuroblastoma cells expressing trkB.TK7 receptors appear to display a more dierentiated phenotype. Nakagawara et al (1994) have shown that the trkB.TK+ receptor and BDNF are expressed almost exclusively in aggressive, immature neuroblastoma tumors, often accompanied with overexpression of Nmyc, whereas the trkB.TK7 is preferentially expressed in more dierentiated tumors, such as ganglioneuromas and ganglioneuroblastomas. In this study, we have investigated the properties of trkB.T1 isoform by transient transfection into mouse N2a neuroblastoma cells. To our surprise, we observed that expression of trkB.T1 isoform led to a dramatic morphological change characterized by outgrowth of ®lopodia and processes. Our results suggest that trkB.TK7 isoforms may play a previously unexpected role in the regulation of cellular morphology.
Results

The eects of transfected trkB receptor variants on N2a cells
The alternatively spliced trkB receptor variants, trkB.TK+ and trkB.T1, were transiently transfected into N2a mouse neuroblastoma cells in order to study their function and properties. FLAG-tagged trkB receptor constructs were created to avoid antibody cross-reactivity. There were no detectable dierences in the ability of BDNF to induce autophosphorylation between the FLAG-tagged trkB.TK+ or the wild-type trkB.TK+, indicating that the insertion of FLAG peptide did not interfere with the ability of BDNF to bind and activate FLAG-trkB (data not shown). Cells which were successfully transfected were identi®ed by FLAG tag antibody staining as described in Materials and methods. The number of cells displaying ®lopodia or processes was scored with the observer blind to transfected plasmid or treatment.
Unexpectedly, we observed a dramatic morphological change in over 50% of the cells transfected with trkB.T1 (Figure 1c ± f), which is characterized by ®lopodia formation (see Figure 1c ) and process sprouting (see Figure 1d and e). The rest of the trkB.T1 transfected cells remained spherical. Confocal microscopy con®rmed that trkB.T1 was expressed on the cell membranes of the soma, ®lopodia, and processes ( Figure 1f) . The control cells transfected with green¯uorescent protein (GFP) retained wildtype N2a cell phenotype with mostly spherical shape and with some cells displaying processes (Figure 1a) . The trkB.TK+ transfected cells were mainly spherical and only few cells extended processes (Figure 1b) .
The number of trkB.T1 transfected cells with ®lopodia or process outgrowth was quanti®ed at dierent time points after the transfection. At 48 h after the beginning of the transfection, *50% of the cells had ®lopodia (Figure 2a ) and almost 30% of the cells exhibited both ®lopodia and processes (Figure 2b ). These numbers were signi®cantly dierent (P50.001, Student-Newman-Keuls) from those of the control cells. Only very few cells displayed processes without ®lopodia. Cells transfected with trkB.TK+ did not express signi®cantly more ®lopodia or processes than the control cells at any time points investigated (Figure 2a and b) . The cell morphology induced by trkB.T1 expression did not change signi®cantly during up to 96 h (Figure 2a and b). At 72 and 96 h only few trkB.TK+ transfected cells could be found, but those found were essentially devoid of ®lopodia and processes. The reason for the low amount of trkB.TK+ positive cells after 48 h is not clear, but TUNEL staining (see below) indicates that this is not due to excess apoptotic cell death.
The cells were grown on glass coverslips coated with poly-L-ornithine, laminin or ®bronectin to test the dependence of the morphological change on growth substratum. Numbers of cells extending ®lopodia or processes were not signi®cantly dierent on any of the three substrata (Table 1) indicating that the extracellular matrix components tested did not aect the morphology of the trkB.T1 transfected cells.
TrkB.T1 positive ®lopodia (as detected with anti-FLAG antibody) also stained positive for actin ®laments (as detected with phalloidin staining), but did not contain microtubuli (as detectable by anti-MAP-1b antibody), whereas FLAG-positive processes contained both actin ®laments and microtubuli (data not shown). TrkB.T1 transfected cells were not stained by antibodies against growth-associated protein GAP-43 (Skene et al., 1986) , synaptophysin (Fletcher et al., 1991) , or glial-®brillary acidic protein (data not shown), indicating that they had not acquired characteristics of mature neurons or glia.
BrdU labeling was used to investigate whether the trkB.T1 induced changes in the N2a cell morphology were accompanied by changes in cell proliferation rate (Figure 3) . Transfected or nontransfected control cells were labeled with BrdU in the absence or presence of BDNF. Over 60% of nontransfected controls were positive for BrdU labeling. In contrast, only 11% of the trkB.T1 transfected cells were labeled (Figure 3) , indicating that the proliferation rate was reduced. Addition of BDNF did not signi®cantly in¯uence the number of BrdU positive cells. Transfection with trkB.TK+ also reduced cell proliferation (Figure 3 ). TUNEL (TdT-mediated dUTP nick end labeling) staining revealed that N2a cells transfected with neither trkB.T1 nor trkB.TK+ showed more apoptotic cell death when compared to the control cells (data not shown).
The eects of trkB.T1 transfection on other cell types
To determine whether trkB.T1 induced morphological change was cell-type speci®c, mouse NIH3T3 fibroblasts and human SH-SY5Y neuroblastoma cells were transfected. The majority of trkB.T1-positive 3T3 cells showed a phenotype strikingly similar to N2a cells, as characterized by ®lopodia formation and process outgrowth (Figure 4b and c), although some of the FLAG-positive 3T3 cells retained a more ®broblast-like Table 1 The eect of substrata on the morphology of trkB.T1
transfected N2a The eects of exogenous ligands on the morphology of trkB.T1 transfected N2a cells
The eects of the trkB receptor ligands, BDNF and NT-4, on the cell morphology of trkB.T1 transfected N2a cells were determined both in the absence and presence of serum in the culture media. As reported previously, serum-starvation per se induced spontaneous process outgrowth (Seeds et al., 1970) , but not ®lopodia formation, as indicated by the serum-starved GFP transfected control cells, which sprouted twice as much as the GFP transfected cells cultured with serum ( Figure 5b ). Serum de®ciency did not aect the number of trkB.T1 transfected cells extending ®lopodia or processes ( Figure 5a and b). Addition of BDNF (50 ng/ml) did not have signi®cant eects on the ®lopodia or process outgrowth of trkB.T1 transfected cells either in the absence or presence of serum when compared to the untreated trkB.T1 transfected cells (Figure 5a and b). A lower concentration of BDNF (5 ng/ml) or cotransfection of a BDNF expression plasmid together with trkB.T1 plasmid also failed to have a signi®cant eect on the ®lopodia or process formation (data not shown). NT-4 (50 ng/ml) did not have a signi®cant eect on the ®lopodia or process outgrowth when compared to the untreated cells. However, cells which were treated with NT-4 in the absence of serum had signi®cantly fewer processes than the NT-4 treated cells cultured in the presence of serum (Figure 5b ; 23+4% vs 40+1%, P50.01, TukeyKramer). The reason for this eect is presently unknown. Treatment of trkB.TK+ transfected N2a cells with exogenous BDNF or NT-4 did not induce sprouting of ®lopodia or processes, and the cells showed a mainly spherical phenotype (data not shown).
Expression of endogenous trkB variants and ligands in N2a cells
N2a cells have been reported to express trkA and trkC receptors, but not trkB (Pastor et al., 1994) . We investigated whether trkB receptor variants or its cognate ligands, BDNF and NT-4 were expressed in our N2a cells using RT ± PCR and hybridization ( Figure 6 ). Total RNA from mouse brain, which was reverse transcribed to cDNA or corresponding plasmids were used as positive controls. The PCR products were blotted and hybridized with their (Figure 6a ). The possibility that endogenous ligands may regulate or be necessary for the trkB.T1-induced morphological change was tested by neutralizing BDNF with a function blocking antibody (Toma & Kaplan, 1997) or by blocking the eects of both BDNF and NT-4 by using trkB-IgG molecules . The presence of BDNF blocking antibody or trkB-IgG did not have any eects on the altered phenotype of trkB.T1 transfected N2a cells (Figure 6b) . These data clearly demonstrate that the morphological change induced by trkB.T1 is independent of trkB ligands.
The low-anity neurotrophin receptor (p75 LNTR ) has been shown to modulate the functions of trk receptors (Hempstead et al., 1991) . Immunostaining with antip75 LNTR antibody revealed that p75 LNTR is indeed expressed in N2a cells (data not shown), suggesting that it could play a role in the morphological change. However, the REX antibody, which blocks the function of p75 LNTR (Weskamp and Reichardt, 1991) did not in¯uence the formation of ®lopodia or processes in trkB.T1-transfected N2a cells at any of the three concentrations tested (Figure 6b ), strongly indicating that p75 LNTR is not involved in the trkB.T1 induced morphological response.
Cotransfection of N2a cells with trkB.TK+ and trkB.T1
The eect of cotransfection of the two receptor variants was studied by transfecting N2a cells with Figure 6 (a) Expression of endogenous trkB.TK+, trkB.T1, BDNF and NT-4 mRNA in N2a cells. Representative autoradiographs overexposed for 24 h of RT ± PCR products (size indicated on the left) of trkB.TK+, trkB.T1, BDNF and NT-4 hybridized with corresponding probes under stringent conditions are shown. Total RNA extracted from mouse brain and transcribed to cDNA (B) or corresponding plasmids (P) were used as positive controls. Reactions without template were used as negative controls (not shown). The arrows on the right indicate the location of the correct band. The symbols for the template sources used are: P, plasmid; B, mouse brain; N2a, N2a cells (two independent experiments are shown). In the case of NT-4, a double band from mouse brain cDNA was ampli®ed, but in the samples from N2a cells only the lower band was hybridized. (b) The eects of anti-BDNF neutralizing antibody, trkB-IgG molecules or p75 LNTR blocking antibody (REX) on the morphology of trkB.T1 transfected N2a cells at 48 h after the transfection. Anti-BDNF (10 mg/ml), trkB-IgG (20 mg/ml) or REX (1 : 100 shown, dilutions 1 : 300 and 1 : 1000 produced identical results) were incubated with the cells for 24 h. The number of cells displaying ®lopodia or processes were scored from 100 successfully transfected cells (assayed by FLAG staining). Results shown are mean of at least four independent experiments+s.e.m. The symbols used are: GFP, green¯uorescent protein; T1, trkB.T1 1 : 1 ratio of trkB.TK+:trkB.T1 expression plasmids. The results show that expression of trkB.TK+ signi®cantly suppresses the trkB.T1-induced morphological change (Figure 7a and b) . Addition of BDNF (50 ng ml) did not further potentiate the eects of trkB.TK+ (Figure 7a and b) . Addition of tyrosine kinase inhibitor K252a (200 nM) reversed the inhibitory eect of trkB.TK+, indicating that activation of the tyrosine kinase domain counteracts the morphological response (Figure 7a and b) . Incubation of the cotransfected cells with BDNF and K252a together did not cause suppression of the morphological change, either (Figure 7a and b) . Addition of K252a alone did not signi®cantly in¯uence the trkB.T1 induced morphological response or induce any morphological changes in the cells transfected with trkB.TK+ or GFP (data not shown). These results indicate that the kinase domain of trkB regulates the morphological response induced by trkB.T1 and that the inhibitory eect of trkB.TK+ is dependent on the tyrosine kinase function.
Eects of transfected trkB.T1 receptor deletion mutants on the morphology of N2a cells
To determine which domains of the trkB.T1 receptors are necessary for the morphological change, a set of deletion mutants was created and transfected into N2a cells (Figure 8 ). The trkB.DIC construct lacks the T1 isoform-speci®c 11 C-terminal amino acids. In the trkB.DTM construct all of the intracellular amino acids of the receptor were deleted. The trkB.DEC construct lacks the major part of the extracellular domain (nucleotides 704 ± 1593). Transfection of trkB.DIC Figure 7 The eect of trkB.TK+ cotransfection on the ®lopodia (a) and process (b) sprouting of trkB.T1 transfected N2a cells at 48 h after transfection. BDNF (50 ng/ml) or K252a (200 nM) were added at 24 h after the transfection and incubated for additional 24 h. K252a was added 20 min before BDNF. In each experiment 100 successfully transfected cells were counted (assayed by FLAG staining) and the number of cells displaying ®lopodia or processes were scored. Results shown are mean of four independent experiments +s.e.m. The symbols used are: TK+, trkB.TK+; T1, trkB.T1; TK+:T1, cotransfection with trkB.TK+ and trkB.T1 (1 : 1); +BDNF, cotransfection with trkB.TK+ and trkB.T1 with added BDNF; +K252a, cotransfection with trkB.TK+ and trkB.T1 with added K252a; + BDNF +K252a; cotransfection with trkB.TK+ and trkB.T1 with added BDNF and K252a Figure 8 Scheme showing the structures of two trkB receptor splice variants, trkB.TK+ (TK+) and trkB.T1 (T1), and the mutated trkB.T1 constructs trkB.DEC (DEC; deletion in the extracellular domain), trkB.DIC (DIC; deletion of the T1-speci®c domain), and trkB.DTM (DTM; deletion of the entire intracellular domain) created for the present study. Abbreviations used are: NH 2 , N-terminus; FLAG, FLAG tag; Cys, cysteine-rich domains; Leu, leucine-rich repeats; IgG, immunoglobulin-like domains; JM, juxta-membrane region; TK, tyrosine kinase domain; COOH, Cterminus Truncated trkB affects neuroblastoma cell morphology A Haapasalo et al construct into N2a cells produced a change in the cell morphology, which was indistinguishable from that produced by wild-type trkB.T1 transfection (Figure 9a and b). TrkB.DTM transfected cells appeared to display as many processes as the cells transfected with trkB.T1, but showed a slightly reduced ®lopodia outgrowth (Figure 9a and b) . These results indicate, that the intracellular part of the trkB.T1 is not necessary for the morphological response. The trkB.DEC construct failed to induce signi®cant morphological changes (Figure 9a and b) , indicating that the extracellular part is required for the response.
This result also con®rms that the presence of FLAG tag in the extracellular part of trkB.T1 is not responsible for the morphological change.
Discussion
We have here examined the function of truncated trkB receptors by transiently transfecting tagged trkB.T1 cDNAs into N2a mouse neuroblastoma cells. Surprisingly, we found that the expression of the trkB.T1 receptor isoform led to a ligand-independent change in cellular morphology characterized by a robust outgrowth of ®lopodia and processes, a phenotype that is remarkably dierent from that of the N2a cells transfected with GFP or trkB.TK+. A similar kind of morphological response was observed when SH-SY5Y human neuroblastoma cells, and also NIH3T3 ®broblasts were transfected with trkB.T1 expression plasmid, indicating that the response is not restricted to cells of neuronal lineage. Antibody staining of trkB.T1 transfected N2a cells indicated that the cells did not acquire a phenotype of dierentiated neurons or glia at least within the time frame investigated here. The morphological change was accompanied by a *90% reduction in proliferation rate. Transfection of trkB.TK+ did not produce morphological changes, but did inhibit proliferation of N2a cells.
Several functions have been suggested for truncated trkB receptors. They may act as dominant negative receptors by heterodimerizing with the full-length forms and thereby preventing their autophosphorylation and downstream signaling, when both are coexpressed within the same cells (Eide et al., 1996; Ninkina et al., 1996) . The most straight forward explanation of the morphological response elicited by trkB.T1 transfection is that N2a cells express an endogenous trkB.TK+ receptor and a ligand, which mediate an autocrine mitogenic signal in these tumor cells. Transfected trkB.T1 form would act as a dominant negative receptor to inhibit mitogenic signaling and induce spontaneous morphological change. However, N2a cells do not express any splice variants of trkB endogenously. Further, a similar kind of morphological response was found when NIH3T3 ®broblasts, which do not express any trk receptors (Glass et al., 1991; Klein et al., 1991b) were transfected with trkB.T1. Finally, inhibition of the tyrosine kinase function in trkB.TK+ transfected N2a cells did not induce a morphological response as would be expected if trkB.T1 would act as a dominant negative receptor. These results indicate that the ®lopodia-inducing eect of the transfected trkB.T1 can not be explained by competition with an endogenous trkB receptor.
Addition of exogenous trkB ligands BDNF or NT-4 did not in¯uence ®lopodia or process outgrowth induced by trkB.T1 transfection. N2a cells express small amounts of BDNF and NT-4 and it is therefore possible that the ligands completely saturate the transfected receptors so that exogenous ligands would not produce any additional eects. However, the amounts of BDNF and NT-4 appear to be very low, much lower than those in mouse brain neurons and it is questionable whether these small amounts are sucient to completely saturate the transfected receptors. Furthermore, neutralization of BDNF by Figure 9 The eects of the deletion mutation constructs of trkB.T1 on the morphology of transfected N2a cells. In each experiment 100 successfully transfected cells were counted and of those the number displaying ®lopodia (a) or processes (b) were scored. Results shown are mean of four independent experiments +s.e.m. The symbols used are: GFP, green¯uorescent protein; T1, trkB.T1; DEC, trkB.DEC; DIC, trkB.DIC; DTM, trkB.DTM as indicated in Figure 8 Truncated trkB affects neuroblastoma cell morphology A Haapasalo et al an antibody or both BDNF and NT-4 function by trkB-IgG molecules had no eect on the morphological response, indicating that endogenous ligands are not involved. In conclusion, the morphological response induced by trkB.T1 transfection appears independent of both added and endogenous ligands. Interestingly, cotransfection of trkB.TK+ form together with trkB.T1 isoform counteracts the morphological response and this inhibitory eect can be blocked by a tyrosine kinase inhibitor K252a. These data suggest that trkB.TK+, perhaps activated by the endogenous ligands, directly or indirectly interacts with the truncated receptor and inhibits its function. The trkB knock-out mice generated by Klein et al. (1993) carry a mutation in the kinase domain but still express the truncated isoforms. If the TK+ isoform inhibits the T1-induced ®lopodia formation also in vivo, it is possible that cultured neurons from these mice display increased process outgrowth. To our knowledge, such an eect has not been reported, but it would be an interesting hypothesis to be tested.
Deletion mutants lacking the T1-speci®c intracellular domain (trkB.DIC) or all the intracellular amino acids of trkB (trkB.DTM) also induced ®lopodia and processes. In contrast, the mutant lacking a bulk of trkB extracellular domain (trkB.DEC) failed to cause the response. These data indicate the necessity of the extracellular, but not the intracellular part of the receptor for the response. This result is interesting as the extracellular and membrane-spanning domains of trkB.T1 and the intracellular deletion mutants are exactly identical to those of trkB.TK+ Schneider and Schweiger, 1991) . One interpretation of this observation is that trkB.T1 interacts with another molecule, which mediates the induction of morphological change. Because trkB.TK+ inhibits the change in cell morphology, intracellular domain of this isoform would prevent it from interacting with this putative molecule. Further experiments are required to delineate the domains and amino acids in the extracellular region that mediate this response and to identify the interacting molecules.
One candidate molecule to interact with trkB could be p75 low-anity neurotrophin receptor (p75 LNTR ), which has been shown to interact with trk receptors and modulate their responses (Hempstead et al., 1991) . p75 LNTR could interact speci®cally with trkB.T1 form and help to induce the morphological response. Conversely, it is also possible that p75 LNTR interacts only with trkB.TK+ and not trkB.T1, and that this interaction would inhibit the response. Although p75 LNTR is expressed in N2a cells, an antibody that blocks its function did not in¯uence process outgrowth induced by trkB.T1 transfection in these cells. The fact that trkB.T1 transfection induced a morphological response also in NIH3T3 cells, which do not express endogenous p75
LNTR (Glass et al., 1991 , Jing et al., 1992 further argues against the role of p75 LNTR in the morphological response.
Experiments with a microphysiometer device have recently suggested that truncated trkB receptors mediate signal transduction of their own (Baxter et al., 1997) . The nature of this signaling remains unclear but it could be hypothesized that the ®lopodia response observed here is a morphological counterpart of this signaling event. However, in contrast to the ®ndings of Baxter et al. (1997) , the response observed by us is independent of neurotrophins. Furthermore, deletion mutants demonstrate that while the intracellular trkB.T1 sequence was critical for the signaling event (Baxter et al., 1997) , it is not necessary for the process outgrowth. Together these data suggest that the morphological response does not re¯ect the same signaling event that has been observed with a microphysiometer.
The extracellular domain of trk receptors share homology with many adhesion molecules, such as N-CAM (neuronal cell adhesion molecule) (Schneider and Schweiger, 1991) . Drosophila trk homologue promotes cell adhesion by homophilic interaction of the extracellular domains (Pulido et al., 1992) . Tannahill et al. (1995) have demonstrated that coating of cell culture dishes with trkA ectodomain inhibits neurite outgrowth, indicating that this domain in¯uences neuronal adhesion. This eect was mediated by the IgG domains of the extracellular region and was ligand-independent, because extracellular domains of trkA or trkB inhibit neurite outgrowth of PC12 cells which do not express neurotrophins. Furthermore, it has been shown by Zhou et al. (1997) that trkB is coexpressed with cadherins and catenins at cell-cell contact sites and that both these two molecules are required for adhesion of stable trkB transfectants of NIH3T3 cells. Our experiments show that the extracellular region is required for the process outgrowth response. The current data are consistent with the notion that the extracellular domain of trkB.T1 may be involved in cell adhesion and in this way regulate the cellular morphology.
Intracellularly truncated splice variants are expressed, in addition to trkB, also from the trkC gene (Tsoulfas et al., 1993) . Although the truncated receptors are abundantly expressed, particularly in the mature CNS, their physiological role has remained unclear. Our results suggest a new role for truncated trkB in the regulation of cell morphology and adhesion. It will be important to determine whether the morphological response is restricted to the trkB.T1 isoform or whether truncated forms of trkC also display a similar kind of function.
Our results may also have clinical implications in the diagnosis or treatment of brain tumors, because neuroblastomas, which express trkB.TK7 generally tend to be more dierentiated and benign than those that express trkB.TK+ (Nakagawara et al., 1994) . Thus, the morphological changes induced by trkB.TK7 expression might underlie the differentiation of the neuroblastomas into a benign phenotype.
Materials and methods
Materials
BDNF and NT-4 were obtained from PeproTech EC Ltd. (London, UK). Polyornithine and laminin were obtained from Sigma (St Louis, MO, USA) and ®bronectin from Calbiochem (La Jolla, CA, USA). Cell culture reagents were from Gibco BRL (Gaithersburg, MD, USA). N2a mouse neuroblastoma cells (CCL-131) and NIH3T3 ®broblasts (CRL-6361) were from American Type Cell Collection (ATCC, Rockville, MD, USA). SH-SY5Y human neuroblastoma cells were obtained from Dr Antero Salminen, Department of Neurology, University of Kuopio (Finland). Rhodamine phalloidin was from Molecular Probes (Leiden, Netherlands). Antibodies were purchased from the following suppliers: Anti-FLAG BioM2 antibody was from Kodak (New Haven, CT, USA); anti-mouse IgG-FITC conjugate and MAP-5 (anti-MAP-1b) antibody were from Sigma (St. Louis, MO, USA); Texas Red anti-mouse IgG conjugate was from Molecular Probes (Leiden, Netherlands); and anti-BDNF neutralizing antibody from Promega (Madison, WI, USA). p75 LNTR antibody (clone 192) was obtained from Boehringer Mannheim Biochemicals (Mannheim, Germany) and p75 LNTR blocking antibody (REX) was kindly provided by Dr Louis Reichardt (UCSF). TrkB-IgG was a gift from Regeneron Pharmaceuticals (Tarrytown, NY, USA).
Gene constructs
A rat hippocampus cDNA library in the Lambda ZAP II vector (Stratagene, La Jolla, CA, USA) was screened (2610 6 p.f.u.) with a partial length rat trkB.T1 probe. Positive clones were selected, analysed by restriction analysis, and two clones corresponding to trkB.TK+ and trkB.T1 were sequenced and used for the present study as inserts in pBluescript SK + . The cloned trkB.T1 was found to contain a neutral mutation at the nucleotide 1001 (T?C) encoding an amino acid change from alanine to valine (the numbering is according to Middlemas et al, 1991) . Transfection of the alanine or valine form into N2a cells yielded identical results when scored for morphological changes. Unless otherwise indicated, the valine form was used in the experiments shown.
The cDNAs were tagged by insertion of a 24 nucleotide coding sequence (5'-GACTACAAAGACGACGATGAC-AAG-3') producing an eight amino acid FLAG peptide (NAspTyrLysAspAspAspAspLys-C) between the signal peptide and mature trkB N-terminus by PCR using the Megaprimer method (Barik, 1995) .
The expression vectors containing the trkB.TK+ (pTrkB.TK+) and trkB.T1 (pTrkB.T1) were obtained by blunt end cloning of the FLAG-tagged cDNAs into the XbaI site of pEF-BOS (Mizushima and Nagata, 1990) . The mutated construct lacking the T1-speci®c intracellular domain (pTrkB.DIC) was obtained by PCR using pTrkB.T1 as template with the primers 5'-CCC-TGGCCGAGGTGGCA-3' (nucleotides 405 ± 464) and 5' -AAAGTCGACCTAACC TTT CATGCCAAATTCGG -3' (nucleotides 1816 ± 1835, SalI restriction site is bolded, stop codon is underlined). The numbering system used for trkB.T1 in this paper is according to the rat trkB.T1 sequence obtained from GenBank database, accession number M55292 . The ampli®ed product was puri®ed and digested with HindIII and SalI. This product was then exchanged with the wild-type HindIII and SalI fragment of trkB.T1 in pBluescript (Stratagene, San Diego, CA, USA). The entire coding sequence was then subcloned into BamHI and SalI site of pEF-BOS. The mutated construct lacking the whole intracellular domain (pTrkB.DTM) was created by PCR using pTrkB.T1 as template with the primers 5'-GAGTTTGGATCTTGGTT-CAT-3' (nucleotides 3662 ± 3681 in pEF-BOS sequence) and 5'-AAAGTCGACCTAGAGCAGAAGCAGAAGCAGCAT-CACCAG-3' (nucleotides 1726 ± 1752). The ampli®ed product was puri®ed and digested with BamHI and SalI and cloned into pEF-BOS. PCR was performed on a programmable thermal cycler (MJ Research, Watertown, MA, USA) in 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 0.08% Nonident P40, 1 mM MgCl 2 , deoxynucleotides 2.5 mM each, 25 pmoles of each primer and 2 U of Taq polymerase (Fermentas, Vilnius, Lithuania) in a volume of 50 ml. The PCR program was the following for both mutated constructs. The template was denatured (1 ± 4 min, 958C) followed by 31 cycles (60 s, 958C; 60 s, 528C; 120 s, 728C). Final elongation was performed for 7 min at 728C.
The mutated construct lacking most of the extracellular part (pTrkB.DEC) was created by digesting trkB.T1 in pBluescript with HindIII (at nucleotide 704 within the ®rst leucine rich domain) and HincII (at nucleotide 1593 after the second IgG-like domain) (Schneider and Schweiger, 1991) . The HindIII and HincII digested plasmid was blunted and religated to yield pBluescript-TrkB.DEC. In this construct, the ®rst cysteine-rich domain and 22 amino acids of the ®rst leucine-rich area at the N-terminal side and last 92 amino acids of the sequence prior to the transmembrane domain at the C-terminal side of the deletion remained intact. In-frame coding was maintained following the excision. The insert in this construct was digested out with BamHI and SalI and cloned into pEF-BOS. The sequences of all the original and mutated constructs were con®rmed by automated sequencing.
. Reverse transcription ± polymerase chain reaction (RT ± PCR) and Southern hybridization Total RNA was extracted from mouse brains or N2a cells by Trizol reagent (Life Technologies, Gaithersburg, MD, USA). cDNA from 1 mg of total RNA was synthesized with Superscript II (Life Technologies, Gaithersburg, MD, USA) using corresponding 3' primers for each sample. A common 5' primer (5'-ACTGACATCGGGGATACTAC-3', nucleotides 1721 Ð 1740 in mouse trkB.TK+ and 1651 ± 1670 in rat trkB.T1) was used for both trkB.TK+ and trkB.T1. The numbering used for mouse trkB.TK+ is according to mouse trkB.TK+ sequence in GenBank, accession number X17647 (Klein et al., 1989) . The 3' primers were 5'-TGAGCTGACTGTTGGTGATGC-3' (nucleotides 2061 ± 2081 in mouse) and 5'-GTG-TTCTTCTGCTGCTTCTC-3' (nucleotides 2084 ± 2103 in rat), respectively. For BDNF the 5' primer was 5'-GGGACTCTGGAGAGCGTGAAT-3' (nucleotides 198 ± 218) and the 3' primer 5'-CCTTATGAATCGCCAGC-CAAT-3' (nucleotides 759 ± 779). The numbering used is according to mouse BDNF sequence in GenBank, accession number X55573 (Hofer et al., 1990) . For mouse NT-4 (Dr Alexander Parsadanian, personal communication) the 5' primer was 5'-ATTTCTGGCCCCTGAGTC-3' (nucleotides 103 ± 120) and the 3' primer 5'-CGC-AAGCTGTGTCGATCC-3' (nucleotides 585 ± 602). The PCR program and reaction mixture were the same as in the case of the mutated constructs. Either 10 ng of plasmid, one-twentieth (BDNF, trkB.TK+ or trkB.T1) or one-fourth (NT-4) of a reverse transcription reaction mixture were used as templates in PCR. Ten ml of PCR products were applied to 1.2% agarose gel containing ethidium bromide.
The gel was denatured for 30 min (1.5 M NaCl, 0.5 M NaOH) and neutralized 2620 min (0.5 M Tris-HCl, pH 8.0, 1.5 M NaCl). Then the ampli®ed cDNAs were blotted onto nylon ®lter (Amersham, Buckinghamshire, UK) in 106SSC buer overnight. The ®lter was air-dried and cDNAs were attached to the membrane by UV crosslinking.
In hybridizations the following cDNA probes were used: For both trkB.TK+ and trkB.T1 extracellular HindIII and SalI digested fragment from trkB.T1 cDNA; for BDNF HindIII and KpnI digested cDNA fragment; and for NT-4 EcoRI-digested fragment from NT-4 cDNA obtained from Dr Alexander Parsadanian. About 50 ng of each probe was labeled with a-32 P-dCTP using Ready-to-Go dCTP kit (Pharmacia, Uppsala, Sweden) according to kit instructions. The labeled probes were puri®ed using Microspin columns (Pharmacia, Uppsala, Sweden) and their activities were counted with Microbeta scintillation counter (Wallac, Turku, Finland 
Cell culture and transfections
N2a, SH-SY5Y neuroblastoma cells and NIH3T3 fibroblasts were cultured in Dulbecco's minimal essential medium (DMEM) containing Glutamax I and 100 U/ml penicillin and 100 mg/ml streptomycin with or without 10% fetal calf serum. The cells were cultured in a humidi®ed cell culture incubator in 5% CO 2 at 378C. The cells were plated on 12-well plates containing glass coverslips coated with poly-L-ornithine (0.5 mg/ml), laminin (10 mg/ml) or ®bronectin (50 mg/ml) the day prior to transfections. The receptor variants and mutated constructs (3 mg/well) were introduced into the cells by calcium phosphate coprecipitation in BES buered saline (50 mM BES, 280 mM NaCl, 1.5 mM Na 2 HPO 4 ), pH 6.95. Nontransfected cells or cells transfected with red shift green uorescent protein (GFP) in pEF-BOS plasmid were used as controls (for review of GFPs, see Cubitt et al., 1995) . Addition of transfection reagents without DNA into the cell culture had no eect on the cells (data not shown). After an overnight transfection, the cells were washed three times with phosphate buered saline (PBS), pH 7.4, fresh media was added and the cells were cultured for 48, 72 or 96 h after the beginning of the transfections as indicated. The transfection eciency obtained with this method was estimated to be about 10%. In cotransfection experiments, trkB.TK+ or an expression cassette containing BDNF under CMV promoter (see Gene constructs) was cotransfected at 1 : 1 ratio (DNA concentration of each construct was 3 mg) with the trkB.T1 construct into N2a cells. In the ligand experiments BDNF (50 ng/ml), NT-4 (50 ng/ml), anti-BDNF (10 mg/ml) or trkBIgG (20 ng/ml) was added into the culture media at 24 h after the transfection and incubated with the cells for 24 h. In p75 LNTR blocking experiments the REX antiserum (diluted 1 : 100, 1 : 300 or 1 : 1000) was added into the media at 24 h after the transfection and incubated with the cells for 24 h.
Immunocytochemistry FLAG staining The GFP-transfected cells were ®xed in 0.05% glutaraldehyde for 15 min at room temperature and washed twice with PBS. Cells transfected with the receptor variants or mutated constructs were ®xed in ice-cold acetone/methanol (1 : 1), washed twice with Tris-buered saline (TBS; 50 mM Tris, 150 mM NaCl, pH 7.4) containing 1 mM calcium chloride (TBS/Ca 2+ ), incubated for 1 h at room temperature with anti-FLAG BioM2 antibody (10 mg/ml) and washed three times with TBS/Ca 2+ . Cells were then incubated with anti-mouse IgG-FITC conjugate (1 : 100 dilution) for 30 min at room temperature and washed with TBS/Ca 2+ . Finally, the coverslips were mounted on glass slides with Aquatex mounting media (Merck, New Jersey, USA) or Slow Fade mounting media (Molecular Probes, Leiden, Netherlands) and viewed bȳ uorescence microscopy (Olympus Provis, Japan) or laser scanning confocal microscopy (Leica CLSM, Germany).
Bromodeoxy-uridine (BrdU) labeling Cell proliferation of the trkB.T1 transfected N2a cells was measured by using the 5-bromo-2'deoxy-uridine (BrdU) Labeling and Detection kit II (Boehringer Mannheim, Mannheim, Germany). The cells were labeled with 10 mM BrdU for 1 h, washed three times with PBS and ®xed with 70% ethanol in 50 mM glycine buer, pH 2.0. The cells were then washed as before and incubated with anti-BrdU antibody (1 : 10 dilution) for 30 min at room temperature. The cells were washed as above and incubated for 30 min with Texas Red anti-mouse IgG conjugate (1 : 100 dilution) at room temperature, washed twice with PBS and stained for FLAG.
Quanti®cation of the cell phenotypes
The cell countings were done under a¯uorescence microscope. In each coverslip 100 FLAG-stained cells were counted and of those the number of cells extending ®lopodia or processes was recorded. A process was de®ned as a MAP-1b positive extension longer than half of the diameter of the cell soma. In the BrdU experiment the number of BrdU-labeled cells out of 100 FLAG-stained cells was counted. Results shown are means+s.e.m. from 4 ± 7 independent transfections. Data was analysed using Instat (Graph Pad, San Diego, CA, USA).
